After a follow-up period of more than 22 years, patients with coronary heart disease who have an elevated triglycerides level have an increased risk in long-term mortality even after adjusting for cholesterol levels and other factors, according to an analysis of a secondary prevention prospective multicenter randomized, placebo-controlled, double-blinded trial.

A prospective survey sent to adults with congenital heart disease and physicians who treat them identified six symptoms that were relevant to most patients. The symptoms were trouble sleeping; fatigue; low energy levels; anxiety or stress about health; depression, sadness or feelings of helplessness or hopelessness; and cost of medical care.

Former FDA commissioner Margaret Hamburg, MD, discussed her tenure and provided advice to her successor, Robert Califf, MD, in an interview with STAT. Hamburg, who left the agency in April 2015, is now working part-time as a foreign secretary of the National Academy of Medicine.

More than one-quarter of hospital readmissions were considered potentially preventable, according to an observational study of 1,000 general medicine patients readmitted within 30 days of discharge to 12 U.S. academic medical centers.

A Delaware jury ruled in favor of Amgen on March 16 in a patent infringement trial pertaining to monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9).

Emory Saint Joseph’s Hospital in Atlanta is managing more than $2.5 million in inventory. Listen to this webinar to learn more about their inventory management best practices.

For this issue, Cardiovascular Business invited executives from five cardiovascular IT companies to join us for an hour. They tackled every question we asked and more.

An estimated one in 250 U.S. adults have familial hypercholesterolemia, according to an analysis of the 1999 to 2012 National Health and Nutrition Examination Survey (NHANES). The researchers mentioned the estimate was higher than the commonly reported prevalence of 1 in 500 adults but lower than the prevalence recently reported in Europe.